Loading Events

« All Events

  • This event has passed.

[TRAVEL TO SAN DIEGO] Rick Doblin at Psych Congress: MDMA-Assisted Psychotherapy for PTSD: To Phase 3 and Beyond

October 3, 2019 @ 5:30 pm - 6:30 pm

The Premier Educational Conference on Practical Psychopharmacology
October 3–6, 2019 | San Diego, CA

Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—psychiatrists, physician assistants, nurse practitioners, psychologists, primary care physicians, and other mental health professionals—with the foremost experts in mental health to improve patient outcomes through education.

No other mental health conference offers the same breadth and level of comprehensive psychopharmacology education combined with state-of-the-art treatment approaches and emerging research findings.


Rick Doblin, PhD

Founder and Executive Director
Multidisciplinary Association for Psychedelic Studies (MAPS)

Based on data from studies with MDMA, the US Food and Drug Administration has designated MDMA-assisted psychotherapy for PTSD as a Breakthrough Therapy. This session will explore the FDA drug development process for MDMA-assisted psychotherapy for PTSD, including mechanism of action, the results of Phase 2 clinical trials, the design and conduct of Phase 3 studies seeking approval for prescription use, Expanded Access/Compassionate use, potential post-approval regulations requiring trained therapists operating in treatment clinic settings, and cost-effectiveness measures to obtain insurance coverage.


October 3, 2019
5:30 pm - 6:30 pm
Event Categories:
Event Tags:
, ,


Psych Congress